NCT00797277View on ClinicalTrials.gov

Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
SchizophreniaSchizoaffective DisorderAgitation
Interventions
DRUG

IM olanzapine

10mg olanzapine IM

DRUG

IM haloperidol plus lorazepam

IM 5 mg haloperidol plus IM 2 mg lorazepam

Trial Locations (1)

100

Department of Psychiatry, National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Yu-Li Hospital

OTHER

lead

National Taiwan University Hospital

OTHER

NCT00797277 - Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia | Biotech Hunter | Biotech Hunter